SIRT1 and hepatocellular carcinoma: Unquestionable, our results displayed that inhibition SIRT1 could inhibit HBx-mediated HCC cell proliferation and migration, which implied the positive function of SIRT1 inhibitor Nicotinamide in HBV-related HCC treatment.